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Introduction : 
 
Liver tumors account for 1% of all childhood malignancies. Surgical  
 
resection forms the main stay of treatment of liver tumors. History has  
 
witnessed transition of liver surgery from the primitive techniques of amputation  
 
and excision in 1716 to the modern era of anatomic hepatic lobectomy in.1952.  
 
The evolution of hepatic resection, from an imprecise removal of portions of the  
 
liver, accompanied by extensive hemorrhage, to a controlled anatomic procedure  
 
with acceptable risk, represents a major advance in modern surgery.  
 
Appreciation of the segmental distribution of blood vessels and bile ducts within  
 
the liver, was an important landmark in liver resection, which brought about  the  
 
anatomic liver resection in vogue.  
 
Improvements in surgical technique have brought about a sea of change  
 
in the perception of hepatic resection. Also, established long term survivals post  
 
resection have made a strong case for hepatic resection. Advances in life  
 
support, intensive care, anesthetic techniques, blood banking have contributed to  
 
the feasibility and safety of hepatic resection especially in neonates. Further, the  
 
recent developments in control of hepatic parenchymal bleeding such as laser,  
 
ultrasonic dissector, argon beam coagulator have improved the outcome of liver  
 
resection. 
 
At our Institute, we have a considerable burden of liver tumors, as the Institute  
 
with about 600 beds, housing all Paediatric Specialities, with availability of  
 
chemotherapy drugs, attracts referrals from allover the country. We have  
 
attempted to review our Institutional experience in the treatment of liver tumours. 
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Review of literature 
 
 
History 
 
 
Berta, who amputated the protruding portion of the liver, in a patient with 
penetrating injury, did the first surgical removal of a portion of the liver in 1716. 
Barring few isolated reports (Bruns 1870, Lius 1886, Langenbuch 1888), formal 
liver resection was performed by Tiffany in 1890. Wendel has been credited with 
the first authentic case of near total right hepatic lobectomy in 1910. Lortat Jacob 
and Robert in 1952 used extrahepatic ligation of vessels for control of 
hemorrhage. The technique of primary hilar ligation was used in the performance 
of right hepatic lobectomy by Quattelbaum in 1953.Digitoclasia or finger fracture 
technique was described by Fineberg (1956), Tien Y Lin (1958).  
 
Cantlie in 1898 initiated the concept of the functional liver anatomy, which 
was carried on to the culmination of the segmental liver anatomy by Couinaud in 
1981. Martin and Woodman reported hepatic lobectomy for Hepatoblastoma in 
children in 1969.  The importance of complete surgical resection of the primary 
liver tumour for cure was emphasized by the Surgical section of the American 
academy of Pediatrics in 1975. In 1990, Merine et al illustrated a case of 
successful resection of a large solitary liver cyst in right lobe of liver casusing 
significant pressure symptoms requiring resection at presentation in a neonate. 
Tagge et al in 1992 reported a series of 15 children, who underwent 
transplantation for hepatic malignancies. 
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Parker reported a case of an infantile liver lesion, probably 
Hemangioendothelioma, in 1880. Haig Kasabach and Katharine Merritt in 1940 
described the interesting association of thrombocytopenic purpura with liver 
hemangiomas. Dehner and Ishak recognized 3 malignant vascular lesions of liver 
namely Angiosarcoma, Malignant epithelioid hemangioendothelioma and type 2 
hemangioendothelioma. Transformation of type 2 Hemangioendothelioma to 
Angiosarcoma was described by Kirchner(1981), Selby(1992), and Awan(1996). 
Luks (1991) in his work, stated that Mesenchymal hamartomas are the second 
common benign hepatic tumours in children.   
 
Malignant transformation of nonparasitic cysts was reported by Pliskin 
(1992) and Weinmann (1996). Inflammatory pseudo tumours are uncommon 
lesions in liver with fewer than 20 case reports in world literature (Passalides 
1996, Hsiao 1999, Lee DuBoir 2001). 
 
Digitoclasia employed as the basic technique in liver resection concerns 
with hepatic parenchymal division by finger fracture with intrahepatic ligation of 
all vascular elements step by step without prior vascular control (Ton That Tung, 
1957). Bismuth in 1982 combined the basic techniques of Ton That Tung and 
Lortat Jacob, to temporarily occlude the hilum, and proceed with parenchymal 
resection, to end in hepatic vein ligation within the liver. 
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The maneuver of occlusion of vascular inflow by hepatic pedicle clamping at 
the hepatoduodenal ligament, as described by Pringle in 1908, is effective in 
minimizing blood loss during parenchymal resections.  
The wide use of Pringle maneuver attests to the procedural efficacy, safety 
and ease of performance. Makuuchi`s hemihepatic vascular occlusion aimed at 
limiting the ischemic damage only to the side of the liver undergoing resection 
indicated in patients who tolerate liver ischemia poorly. Total hepatic vascular 
exclusion consisting of the combined vascular inflow and outflow occlusion, 
reduces operative blood loss markedly, with the added advantage of extended 
caval resection, in case of tumour involvement of the inferior vena cava.       
 
Described in 1966 by Heaney et al, this procedure has adverse 
hemodynamic effects at times. Fortner et al in 1970 reported major liver resection 
by using total vascular isolation and hypothermic perfusion. This procedure is 
claimed to make possible the undertaking of complex liver resections for which 
portal and hepatic vein dissections are needed. Pichlmayr et al improved 
Fortner`s technique by using the University of Wisconsin solution as the 
perfusate in insitu hypothermic liver perfusion in 1990. 
 
Liver anatomy 
Developments in the understanding of hepatic anatomy have been of vital 
importance in liver resection. Morphologically, as the liver lies in the abdominal 
cavity, it is split into a large right and a small left lobe by the falciform ligament 
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extending from the anterior abdominal wall. The morphological description, 
however, does not correspond to the surgical anatomy of the liver and studies by 
Tung, and most importantly by Couinaud, on the functional anatomy of the liver 
have paved the way to safe hepatic resection.  
Division of the portal inflow divides the liver into two, a right and left 
hemiliver, along the principal plane (Rex-Cantlie line) that passes through the gall 
bladder bed towards the vena cava and through the right axis of the caudate 
lobe. Further subdivisions of the portal inflow divide each hemiliver into 2 
subdivisions termed sectors and then each sector into 2 subdivisions termed 
segments.  
The divisions of the portal vein are mirrored by divisions of the bile duct 
and hepatic artery forming a ‘portal trinity’, and hence the liver can be divided into 
segments, each of which has its own ‘portal trinity’ supplying it. The 3 major 
hepatic veins (right, middle, and left) lie between the 4 sectors in the 3 main 
fissures or scissuras, right, main, and left, respectively, and each vein drains the 
sectors on either side of it. The functional anatomy is not visible on inspection of 
the liver.  
The right hepatic vein separates the two sectors of the right hemiliver 
which lie anterior and posterior. The right anterior sector is subdivided into 
segments V (inferior) and VIII (superior) and the right posterior sector is 
subdivided into segments VI (inferior) and VII (superior). The left vein separates 
the 2 sectors of the left hemiliver, which lie anterior and posterior. The left 
anterior sector is divided into two segments, III and IV. 
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 The left posterior sector is the one exception to the rule as it only has one 
segment, segment II. The caudate lobe is a distinct anatomical segment and is 
labelled segment I. It receives branches of the portal trinity from the right and left 
liver and drains independently into the vena cava.  
 
The right vein drains into the vena cava independently, but the middle and 
left veins usually join and drain into the vena cava as a single vein. There are 
usually a few small veins draining into the vena cava from behind the liver. 
Occasionally there can be 2 or 3 inferior right hepatic veins of moderate size and 
these can provide significant drainage. If these are not recognized and torn 
during hepatic resection, bleeding may be profuse.  
 
As each segment of liver has its own supply from the portal trinity, 
independent of the other segments, they can be resected independently of other 
segments. In practice, it is easier to remove some segments together. Although 
the intersegmental planes are not visible on the surface of the liver, segments 
can be defined by occluding the inflow to that segment thus rendering the 
segment ischaemic and demonstrating the functional division on the liver surface.  
 
It has been recognised that Glisson’s capsule extends as a condensation 
of fascia around the biliovascular branches of the portal trinity (Glissonian 
sheaths). Couinaud and more recently Launois and Jamieson have noted that 
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the fascia continues within the liver parenchyma up to the segmental divisions. 
The surgical implication is that if the supply to an individual segment is 
approached from within the liver, mass ligation of a sheath, will devascularise the 
segment. This is simplified even further by the use of a stapler. 
 
The nomenclature of hepatic resection remains confusing with differing 
terminology used in the literature. The contrast is between the American 
terminology of Goldsmith and Woodburn and that of Couinaud. It is important that 
precise descriptions of what part of liver is to be resected are used. 
 
Liver tumors  
 
Of all liver masses in children, two thirds are malignant,  Hepatoblastoma 
accounting for the majority of malignant tumors.  
Benign tumors include  
Hemangiomas     Inflammatory pseudo tumour 
Hepatic cysts     Hemangioendothelioma 
Teratoma      Mesenchymal hamartoma 
Angiomyolipoma                                   Adenoma    
Focal nodular hyperplasia                        Biliary cystadenoma 
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Malignant tumors include 
Hepatoblastoma        Histiocytosis 
Hepatocellular Ca                  Leukemia 
Angiosarcoma        Leiomyosarcoma  
Hemangioendotheliosarcoma                Lymphoma   
Embryonal sarcoma        Neuroblastoma 
 
Hepatoblastoma has noted associations with several syndromes such as 
Beckwith-Wiedemann syndrome, Familial adenomatous polyposis, Li Fraumeni 
syndrome, Prader-Willi syndrome and Trisomy 18. Similar notorious associations 
of Hepatoma include Tyrosinemia I, Glycogen storage disease type I, Alagille 
syndrome, Alpha1 antitrypsin deficiency. Hepatic tumors have been postulated to 
occur with the association of Neurofibromatosis, Tuberous sclerosis, Ataxia 
telengiectasia and Fanconi`s anemia.  
 
Other reported links include Hepatitis B, Total parenetral nutrition, foetal 
alcohol syndrome, post radiation (Wilms tumour) and post chemotherapy (acute 
lymphoblastic leukemia). 
 
Histopathological subtypes of Hepatoblastoma include fetal, embryonal, 
mixed mesenchymal, macrotrabecular and anaplastic or small cell types. The 
importance of subtyping is the association between prognostic risk and subtype.  
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Studies have attested to the fact, that foetal subtype is associated with an 
improved prognosis. In contrast, patients with anaplastic variety usually do 
poorly. Interesting associations observed to occur with Hepatoblastoma are the 
presence of thrombocytosis and extramedullary hematopoiesis. Ability to secrete 
interleukin 1, erythropoietin and stem cell factor may probably account for the 
presence of thrombocytosis. 
 
Liver regeneration 
 
The capacity of liver to regenerate has been recognized long back, as 
demonstrated by the greek legend of Prometheus. 
Liver growth is a multistep process in which both growth stimulating and 
inhibiting factors are involved. Although all liver cells retain the ability to replicate, 
in normal conditions only a few hepatocytes undergo proliferation. This situation 
changes when the functional liver mass is reduced by surgical resection or 
noxious stimuli such as virus, toxin. 
There is a burst of proliferation with the regenerative process leading to 
full restoration of hepatic mass over a period of 6 weeks. 
Several factors have been identified to be involved in the modulation of hepatic 
regeneration including –  
Initiators – ions, nutrients, hormones 
Progressors –T3, TGF alpha, HGF 
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Augmenters – Insulin, IGF II, FK 506, Cyclosporin A, ALR (Augmenter of Liver   
                         Regeneration) 
Inhibitors – TGF beta, IL 1,6 
It has been found that some degree of hepatic regeneration occurs with 
every transplant and the factors controlling the regeneration reside principally in 
the recipient environment. 
 
Investigations  
 
Preoperative evaluation is an essential prerequisite to the safe 
performance of liver resection. The management protocol should be based on 
studies, which would establish the respectability of the lesion, based on the 
relationship to the vital structures. Evaluation of metastatic disease outside the 
liver is also mandatory. Estimation of hepatic reserve based on radionuclide 
studies would form an important tool in the background of cirrhosis. 
 
Ultrasonography has stood the test of time as the major diagnostic tool as 
it is noninvasive, inexpensive, quick to perform, and can be manipulated into any 
plane so as to optimize visualization of anatomic structures. 
Recent improvement in the use of Ultrasound has improved respectability rates, 
when applied laparoscopically and per operatively. Use of Ultrasound in the 
intraoperative setting has improved resolution with increased sensitivity to 
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identify parenchymal vascular anatomy and extent of tumour involvement, 
helping in surgical decision making. 
 
With the development of ultrasound probes designed for use through 
Laparoscopic ports, the technique of Laparoscopic Ultrasonography has 
emerged as a sensitive staging technique, determining respectability of tumour 
and also assists in the performance of liver resection. Doppler Ultrasonography 
can identify occult metastases based onhepatic perfusion index – ratio of hepatic 
arterial inflow to total liver inflow ( Leen et al). Also, through the identification of 
efferent tumoral vessels and characterization of intratumoural blood flow, Doppler 
Ultrasound can aid in the differential identification of regenerative hyperplastic 
nodules and tumour nodules. 
 
Preoperative angiography can provide useful information in that a clear 
roadmap of the hepatic arterial anomalies is available and is of value in the 
surgical resectiuon from a technical standpoint.It is to be noted that hepatic 
arterial anomalies can occur in upto 50% cases. Carbon dioxide Ultrasound 
Angiography is a recent innovation utilizing a mixture of  CO2 microbubbles and 
the patient`s blood, as slow injection into hepatic artery. It is claimed that the 
micro vasculature appears enhanced accentuating the image of neoplasms not 
easily seen using standard ultrasound.  
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Computed tomography has proved its superiority over sonography in view 
of higher sensitivity less operator dependence better anatomic definition easy 
interpretation. Newer techniques such as spirl scan mode and arterial 
portography have increased the imaging sensitivity and increased the ability to 
predict the presence and exrtent of the lesions in liver in particular neoplastic 
lesions. Information on diffuse diseases of the liver, hepatic vasculature and 
cirrhosis are reliably provided by CT. Portal vein thrombosis lends itself to prompt 
detection by CT. Another area where CT plays an important role is the 
assessment of tumour burden based on three dimensional volumetric 
informnation and automated CT based techniques which provide accurate 
estimatiuon of percentage hepatic rep[lacement by tumour, for assessment and 
monitoring of patients.  
 
MR imaging with Gadolinium chelate injection intio the superior 
mesenteric artery and use iof the FLASH- fast low angle shot technique has been 
shown to have high sensitivity for imaging of liver tumors providing superior 
quality images. 
 
Liver function tests, Tumour markers (alpha foeto protein), Isotope 
studies, Laparoscopy, Sonographic guided biopsy form the complete 
armamentaria for investigation of liver tumors. 
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Liver resection techniques 
 
A number of abdominal incisions can be used for liver resection. A 
bilateral subcostal incision provides good access and usually is made by 
extending an exploratory right subcostal incision to confirm there is no 
unexpected peritoneal disease. An upwards extension to the bottom of the 
sternum to form a Mercedes-Benz incision can be made to allow wider access. A 
costal retractor such as a Rochard may be used.  
 
A mid-line incision with a right costal extension is also practical. Following 
an exploratory laparotomy, the liver is mobilized from its peritoneal attachments. 
The falciform ligament is divided, with particular care superiorly where the 
hepatic veins enter the inferior vena cava. The right coronary ligament, with its 
anterior and posterior leaves around the bare area of the liver and its fused 
caudal extension as part of the triangular ligament, is divided to mobilize the right 
liver. The left triangular ligament is divided to mobilize the left liver, though for 
extensive right-sided resections, it may be preserved to prevent liver rotation and 
venous outflow occlusion post resection.  
 
The main hepatic pedicle can be approached from outside or from inside 
the liver substance. The extrahepatic approach was first described by Lortat-
Jacob and co-workers in 1952 in a report of a right hemihepatectomy. The free 
edge of the lesser omentum is opened, the portal vein, hepatic artery, and 
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common bile duct followed up to their divisions, and the appropriate side 
dissected and divided. Dissection can be time consuming and anatomy 
may vary. Division may be high and close to the porta hepatis. Misidentification 
and ligation of the wrong vessels may devascularise an area of liver that is not 
planned to be resected. The hepatic veins may be dissected extrahepatically in 
the case of both the right vein and the middle/left vein, whether combined or prior 
to their joining. The veins are wide and accidental damage may result in 
catastrophic and uncontrollable haemorrhage. 
 
The hepatic pedicles may be approached directly by the anterior 
intrahepatic approach. This was first described by Tung  and involves dissection 
of the hepatic parenchyma along the hepatic fissures and ligation of the pedicles 
directly within the liver. The problems are that the fissures are not identifiable on 
the liver surface and, prior to pedicle ligation, there are no identifiable boundaries 
between the segments. There may be considerable haemorrhage as the pedicles 
are ligated after paren-chymal dissection. This method is necessary to ligate a 
portal triad to an individual segment and intra-operative ultrasound can aid 
identification of the appropriate portal triads. The hepatic veins may also be 
ligated within the liver substance. 
 
 The advantage is that this reduces the risk of damaging the vein, but the 
disadvantage is that ligation of the vein tends to have to be late in the resection 
and hence haemorrhage may again be considerable.  
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The hepatic pedicles may be approached by the posterior intrahepatic 
approach described by Launois and Jamieson which utilizes the Glissonian 
sheaths. Incisions of the liver capsule around the porta hepatis allow limited 
intrahepatic dissection. Dissection along the sheaths around the portal triads 
provides access to the main trunk sheaths supplying an entire hemiliver, further 
within to sectorial divisions, and then to segmental divisions. Clamping of these 
divisions may be used to confirm identification by devitalisation of the supplied 
segment(s) and the appropriate sheath may then be ligated. Excellent results 
have been reported with this method. 
 
Hepatic vascular control 
The potential of severe haemorrhage during liver resection and the 
resulting morbidity has already been mentioned. Bleeding maybe a particular 
problem during parenchymal transection. A number of techniques of hepatic 
vascular control of inflow and outflow are available and, though liver resection 
can be performed without vascular control, the use of vascular control can result 
in very low blood losses. Alternative techniques to reduce parenchymal bleeding 
such as use of a hepatic tourniquet or instruments to compress the parenchyma 
are not generally used.  
 
This is the original technique described by Tung with direct dissection 
through the liver parenchyma to the inflow and outflow of the area to be resected 
with no other vascular control.  
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It has the advantage of no risk of erroneous ligation of hilar structures, but, 
unless performed quickly, bleeding is substantial from the transection 
surface,particularly if coagulation is impaired such as with cirrhosis. Identification 
of the hepatic fissures may also be problematic as perfusion of the hepatic 
segments remains uniform during transection.  
The extrahepatic approach to the hilar vessels and hepatic veins 
described by Lortat-Jacob does provide vascular haemorrhage as the pedicles 
are ligated after paren-chymal dissection. This method is necessary to ligate a 
portal triad to an individual segment and intra-operative ultrasound can aid 
identification of the appropriate portal triads. The hepatic veins may also be 
ligated within the liver substance. The advantage is that this reduces the risk of 
damaging the vein, but the disadvantage is that ligation of the vein tends to have 
to be late in the resection and hence control prior to transection of the liver 
parenchyma.  
 
The advantages are that the area to be transected is well demarcated 
prior to transection as it is devascularised, and that intra-operative haemorrhage 
is minimal. The disadvantages are that inappropriate ligation at the porta hepatis 
is possible and dissection of the hepatic veins may be difficult, with the risks of 
severe haemorrhage and air embolism. It is also not possible if resection of a 
segment alone is undertaken. 
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Temporary vascular occlusions of the liver 
A number of techniques of occlusion of hepatic inflow are available which 
may be combined with occlusion of hepatic outflow. 
Total inflow occlusion 
Pringle first described total clamping of the hepatic pedicle or the Pringle 
maneuver in 1908 to reduce hepatic haemorrhage secondary to trauma. It is 
probably the most common method of minimizing blood loss during parenchymal 
resection and involves ‘en masse’ clamping of all the structures of the hepatic 
pedicle present in the free edge of the lesser omentum with a non-crushing 
clamp. Nagasue et al. and Kim et al. have compared hepatic resections of 
cirrhotic livers with and without the Pringle maneuver and have shown a 
significant reduction in intra-operative blood loss, postoperative complications, 
and mortality in the group in which the Pringle maneuver was used.  
 
Studies in which both cirrhotic and non-cirrhotic patients underwent 
hepatic resections also demonstrated a significant improvement using the Pringle 
maneuver. Inflow occlusion does result in a haemodynamic response with an 
increase in systemic vascular resistance and a corresponding increase in heart 
rate and mean arterial pressure, but this is usually well tolerated in both non-
cirrhotic and cirrhotic patients. 
Opinion on the safe duration of clamping varies. For a long time, the 
original description by Pringle of 15–20 min of inflow occlusion was considered 
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the limit in a normal liver. Huguet et al.56 reported no major com-plications or 
mortality in a series of resections with inflow occlusions times of 25–65 min with 
a mean of 38 min.Since then, a number of authors have reported continuous 
occlusion times of up to 60 min with few complications, and this is generally 
considered the safe upper limit for normal livers.  
Continuous occlusion up to 90 min has been reported, although this 
duration of warm ischaemia is associated with a significant number of major 
complications such as transient hepatic insufficiency and encephalopathy. 
Use of techniques to lower the central venous pressure (CVP) to 0–5 cm during 
transection has a dramatic effect on reduction of blood loss. Lowering the CVP to 
below 5 cm significantly reduces blood loss, and has resulted in groups 
demonstrating very low intra-operative blood losses. Melendez et al. have done 
this by positioning the patient head down and restricting fluid replacement until 
the resection is completed. Rees et al. used a combination of epidural 
anaesthesia and intravenous nitroglycerine for vasodilatation. Air emboli may 
occur during hepatic surgery, and the risk of this is increased with lowering of the 
CVP. 
 
The hepatic fissures and segmental divisions are not visible on the liver 
surface. Clamping of the inflow as described above, allows ischaemic 
demarcation of the area of liver to be resected and indicates the appropriate line 
of resection. In segmental resection, segmental inflow ligation may not be 
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possible prior to parenchymal transection and the line of resection must be 
estimated 
 The line of division needs to be 5–10 mm to the side of the line of 
ischaemic division along the hepatic fissures to avoid damage to the hepatic 
veins which usually lie within the fissures. The liver capsule is divided with knife 
or diathermy. The aim is to divide the parenchyma and leave the hepatic veins 
and larger branches of the hepatic sheaths containing divisions of bile duct, 
portal vein and hepatic artery. Small branches less than 1 mm may be 
diathermied, but larger branches are clipped or ligated. Segmental branches or 
the main hepatic veins may easily be stapled. 
 
 Meyer-May described the use of Kocher-like clamps to crush liver 
parenchyma in 1939 and haemostatic clamps such as Kelly clamps are still used 
by some units to crush small areas of parenchyma, leaving the vessels intact. 
Lortat-Jacob used the handle of a scalpel  and Lin described the use of finger 
fracture to remove parenchyma. Ultrasonic dissection has been developed using 
a CUSA (Cavitron ultrasonic aspirator). This is an acoustic vibrator, perfused with 
saline, which disrupts the liver parenchyma by producing a cavitational force. 
Diathermy is also in-built into the tip. This has been shown to be very effective for 
division of parenchyma with low blood losses.  
 
The use of other instruments such as water-jet dissection or ultrasonic 
cutting have also been reported. 
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Following division of the parenchyma, any form of vascular occlusion is 
released. Any residual bleeding vessel on the divided liver surface is then 
controlled. Use of argon beam coagulation can be valuable as it can plug vessels 
by creating a surface coagulum. Fibrin glue has been shown to be valuable in 
sealing the liver surface. The falciform ligament must be reconstituted if the right 
liver is resected to prevent torsion of the residual liver, although no ligament 
reconstruction is necessary for a left-sided resection. 
 
There has been a limited application of laparoscopic hepatic resection 
and, although the results have been satisfactory with successful resections in a 
small group, the numbers are too small to make any conclusion as to its 
application on a wider scale. 
 
Liver transplantation : 
 
The final court of appeal for unresectable liver tumour without systemic 
spread is liver transplantation. Favourable results for transplantation in children 
with hepatoblastoma, whose disease is localized to the liver have been reported 
(Superina and Bilik 1996, Douglas 1997). Though this enthusiasm must be 
tempered in those with stage 4 hepatoblastoma, as recurrence is almost 
universal.  
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At times, even benign liver tumors can cause significant morbidity in 
children. Howard reported 20% mortality of the children with benign tumors in his 
series. With present survival rates of post liver transplant approaching 90%, 
children with unresectable or untreatable benign tumours are to be offered the 
option of liver replacement. Primary liver transplantation has been in the cards as 
an option, but significant controversies exist owing to the shortage of the 
availability of donor livers. Howard recommends transplantation for highly select 
group of children, with isolated liver tumours, with caution. The devised strategy 
for these children is 4 cycles of anterior chemotherapy followed by 
transplantation and early post transplant consolidation therapy with 2 more 
cycles of chemotherapy. In a rare instance, as evidenced by Tepetes (1995), 
orthotopic liver transplantation is the only therapeutic option available for an 
extensive unresectable benign tumour. 
 
Recent advances : 
 
Excessive bleeding during liver resection may require time consuming 
hemostasis with attendant complications resulting in increased post op morbidity 
and mortality. Hence researchers were hard pressed for newer methods to 
control bleeding. This led to the emergence of modern gadgets, which achieved 
controlled parenchymal resection with reduced blood loss compared to the finger 
fracture techniques.  
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These include 
i. Ultrasonic dissection (Cavitron UltraSonic Aspirator – CUSA) 
ii. Ultrasonic cutting (Harmonic scalpel) 
iii. Hydrodissection 
iv. Argon Beam Coagulation (ABC) 
v. Laser dissection / cutting 
vi. Cryotherapy 
vii. Radiofrequency electrodissection 
 
Using Ultrasonic dissection, damage to vessels, ducts can be avoided while 
fat or glandular parenchyma is separated. Due to sonic vibration at 25,000/sec, a 
cavitational effect is obtained, the ultrasonic high energy converting water to 
steam. More the water content, more the resultant cavitation effect, causing 
fragmentation of parenchymatous cells and fat. The advantage lies in the fact 
that structures with significant amount of collagen namely the vessels, ducts and 
nerves are left intact for careful ligation eliminating the risk of bleed and thus 
achieving effective hemostasis.  
The glisson`s capsule requires incision by cautery before sonic dissection as 
the liver capsule has low water content.Harmonic scalpel is an innovative 
modification of the sonic dissector with increased frequency of the vibrating tip to 
the tune of 55,000 Hz. The device cuts when the tip is vibrating in the harmonic 
range and also achieves coagulation effect. 
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Hydrojet dissection has been reported as a quick and efficient technique 
for disrupton of the liver parenchyma during liver resection. Varying effects are 
produced on the liver – deep, sharp cutting of all the structures is achieved at 
close quarters, while washing and gentle separation of structures is achieved on 
placing the probe at a distance. 
 
The Argon Beam Coagulator is a technological improvement over its  
 
predecessor – the electrocautery, in that more effective coagulation and  
 
hemostatsis is attained. Gentle flow of Argon conducts radiofrequency current to  
 
the target tissue, resulting in an eschar of uniform depth, and allowing  
 
coagulation within the vessel wall. Smoke production seen in electro-cautery  
 
usage, is absent in ABC, as also the fact that it clears blood from the surface of  
 
target tissue, allowing better visualisation and localization of the bleeding site. 
 
Nd:YAG, CO2 lasers facilitate liver resection by combination of coagulation and  
 
vaporization, although the effect is cutting rather than coagulation on larger  
 
vessels in 2mm range resulting actually in increased blood loss.  
 
Use of Cryotherapy probes and Radiofrequency ablation has been in the 
experimental stage, being advocated for application in treatment of unresectable 
liver tumours. 
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Aim : 
 
i. To study the pattern of presentation of liver tumours in our Institute 
ii. To study the histopathological profile of liver tumours 
iii. To analyse the outcome of liver resection 
 
 
Materials and methods : 
 
The study was a combined retrospective and prospective collection of 
children operated for liver lesions.  
Inclusion criteria for the study - all children who underwent liver resection 
were included in the study from January 1999 – January 2005.  
Exclusion criteria were cases not operated or liver resection done for 
causes other than neoplasms, like trauma. Informed consent was obtained from 
the parents of the children, for inclusion in the study.  
 
   Cases that died or lost for follow up were identified. Otherwise, all cases 
were followed up on a periodic basis i.e  - immediate post surgery every monthly 
till 1 yr, 3 monthly once for II yr, 6 monthly once for III yr, annually thereafter.  
Children underwent a complete clinical examination during the follow up 
visit. 
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 Relevant investigations including chest Xray, Ultrasonography of 
abdomen, complete blood counts, liver function tests and tumour markers were 
carried out during the follow up visits, to ensure detection of loco regional 
recurrence of the malignant neoplasms. 
 If Ultrasonography of abdomen was not satisfactory, in view of high index 
of suspicion of tumour recurrence, CT abdomen was done. The follow up cases 
were discussed in a tumour board, conducted once weekly, comprising of a team 
of specialists including Medical oncologist, Radiotherapist, Pathologist and 
Surgeon. Similarly, all the new tumour cases were discussed by the Tumour 
Board panel, to achieve a consensus opinion regarding surgery with or without 
chemotherapy.  
 
Results : 
 
The study comprised of 21 cases, over a period of 6 years. In our Institute, 
we register about 5-6 new cases of liver tumors annually. Approximately, 750 
new cases were identified to have malignancies per year of which liver tumors 
account for about 1-2 %. 
 
Age distribution 
 
Of the 21 cases, most of them were within the age group of 1-2 years (33%). 6 of 
the children were infants, of whom 2 were neonates.  
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Between 2-3 years, 3 children were enrolled in the study. Older children 
formed a minority as evidenced by the group of 4-5 years consisting of 2 children 
(10%). 10% were between 6-7 years and 5% were between 8-9 years of age. 
The youngest child was 3 weeks of age (fig 3) and the oldest was aged 8 years. 
Overall, 80% of the children were below 3 years of age forming a considerable 
majority over children more than 4 years of age (5 children, 20%). 
Among the study group, 10 were boys and 11 were girls, with an almost equal 
male-female ratio. 
. 
Clinical presentation 
 
The most common presenting complaint was abdominal mass / distension 
of abdomen, seen in 19 out of 21 children (90%). 5 of the children presented with 
anorexia (23%). Fever was present in 23% of the children. 20% of children were 
labeled as failure to thrive in view of inappropriate anthropometry, height and 
weight for age. 10% of the study group had significant weight loss. Pain 
abdomen was the presenting complaint in 2 children (10%). Uncommon but 
interesting presentation in the study group was pseudo-precocious puberty in 2 
children (10%). One of them was diagnosed to have adrenocortical tumor with 
secondaries liver (fig 4), and the other was a beta HCG producing 
Hepatoblastoma. 
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All of them had a palpable mass or hepatomeagaly. 60% of them were 
anemic at presentation. None of the children were icteric, although altered liver 
enzymes were present in 55% of cases. Prothrombin time and biochemical 
parameters were within normal limits in all the cases.  
Ultrasonography and CT scan was done in all the cases for delineating the liver 
tumour and assessing the operability of the lesion 
 
Tumour markers  
 
Alpha foetoprotein, Beta Human Chorionic Gonadotropin assay were 
performed in all the cases. Excluding 5 cases, rest of the 16 cases (70%) 
showed abnormality in the marker profile. Alpha foeto protein was grossly 
elevated above (30,000 ng/mL) in 6 cases (33%). In 5 of the children the levels 
were between 10,000 – 30,000 ng/mL. The levels were between 1,000 – 10,000 
ng/mL in about 3 cases (15%). 10% cases showed mild elevation to the tune of < 
1,000 ng/mL. Beta Human Chorionic Gonadotropin levels were elevated in only 2 
cases. 
 
Histopathology profile 
 
 
The majority (85%,18 out of 21 cases) were found to be malignant on 
histopathological examination. 15% of the cases were identified as benign liver 
tumours. Of the 3 cases reported benign, 2 were Hemangioendotheliomas and 
one was Hepatic adenoma.  
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Among the malignant tumors, Hepatoblastomas form the bulk of the 
group, accounting for 66% of cases, i.e 14 cases out of 21 cases. One of them 
was a Hepatocellular Carcinoma and one was a malignant mesenchymal 
hamartoma. 2 of them were Adrenocortical carcinomas with secondaries liver. 
 
 
Surgical procedures 
 
Pre operative preparation of all the cases involved hydration with 10% 
dextrose and vitamin K. Anemia was corrected before taking up for surgery. 
Chevron incision was used in 8 cases and midline laparotomy was done in 2 
cases. The commonly employed incision was bilateral rectus cutting incision in 
12 cases (55%). 
 
Surgical procedure involved exposure and liver mobilization by cutting the 
ligaments and taking vascular control. Finger fracture method was used for 
parenchymal resection and ligation of the large vessels and ducts done at the 
end of the procedure.  
Among the 21 cases, 16 (85%) of the children under went anatomical 
resections. Non anatomical resections were undertaken in 4 cases.  Re-
resections were performed in the children who underwent non anatomical 
resection, in view of residual disease. In 2 children, concomitant adrenalectomy 
and liver resection were performed for Adrenocortical ca with liver metastases. 
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Majority of the anatomical resections were right hepatectomies (9 children 
out of 16). Less than 50% of the anatomical resections were left lhepatectomies. 
Only one of them underwent segmentectomy. In 5 cases, Pringle`s maneuver 
was performed for reducing blood loss. 
 
Blood utilization 
 
The use of finger fracture technique was associated with increased blood 
loss and hence replacement in the form of blood utilization was generally on the 
higher side. 
 
Barring 3 cases, the vast majority (18 out of 21 cases) were transfused 
with blood. Range of blood utilization varied from 100mL to 5 pints. On an 
average, 1 pint was transfused per child. Among the 18 children who received 
transfusion, the transfusion was done on the basis of preoperative anemia and 
anticipated increased blood loss in 10 cases. Hence, significant blood loss 
requiring transfusion was only in about 8 cases. 
 
Post-operative complications 
 
Immediate complications in the early post-operative period (< 1 week) 
were noted in 8 children (30%).  
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Minor complications like wound infection, gaping, fever and ileus were not 
included in this. Bile leak was seen in 3 cases, of which 2 subsided gradually 
over 2 wks and subsided without any intervention. One of the children who had 
persistent bile leak required intervention. 
 
Significant post-operative hemorrhage was observed in 5 cases, 3 of them 
being managed with fresh whole blood and plasma transfusions. In 2 cases, the 
bleed was severe and could not be controlled, and they expired eventually after 
prolonged stay in the intensive care unit. 
 
In 6 cases, late complications were recorded, beyond the first post-
operative week. One developed an incisional hernia, and the other child 
manifested bilioentero cutaneous fistula, requiring intervention. 4 children went 
on to develop recurrences, which were identified within 6 months post-operative 
follow up. Three of the children with recurrences did not respond to second line 
chemotherapy and expired while awaiting for re-operation. One of the children 
with recurrent liver tumour refused further treatment. 
 
Chemotherapy 
 
Of the 21 children, 15 received chemotherapy. 6 of the children did not 
receive chemotherapy in view of the histopathology report.  
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The children who were not subjected to chemotherapy include 2 
Hemangioendotheliomas, 2 Adrenocortical tumors with secondaries liver, 1 
Hepatic adenoma, 1 Hepatocellular carcinoma. 
The chemotherapy regime consisted of Vincristine, 5 FluoroUracil and 
Cisplatin. 
 
We submit the children for chemotherapy, within 10 days of surgery and 
continue 6 cycles of chemotherapy. Among the 15 children who received 
chemotherapy, only 2 of them were subjected to 2 cycles of neo adjuvant 
chemotherapy in view of doubtful resectability, based on imaging studies. Later, 
these children were followed up with 4 more cycles of chemotherapy post 
resection. 
 
 
 Outcome 
 
Of the 21 cases studied, 13 of them are asymptomatic (65%) at the time of 
conclusion of the study. 20% of the study cases expired, 3 of them due to 
recurrence of tumour and 2 of them developing uncontrolled hemorrhage in the 
immediate post-operative period. 
 
Two cases (10%) were lost for follow up. Among the cases on follow up, 4 
of them were at the end of first follow up year. 
 35
.Two cases have completed 2 year follow up while another 2 cases have 
completed 3 year follow up. 25%(5 out of 21 cases) of the total study cases have 
completed successfully 5 year follow up and they are disease free till date. 
 
 
Discussion: 
 
Our study found a 1-2% incidence of malignant liver tumors, which is in 
accordance with the SEER program cancer registry of the Bethesda cancer 
institute. Also, our annual resection rate of 3 per year is the same as that 
reported by Young et al.  
 
 In our study, the median age at diagnosis was 18 months, for 
Hepatoblastoma, which is consistent with the reports of Exelby et al and Lack et 
al. According to Tomlinson, only 5% of Hepatoblastoma cases were seen in 
children older than 4 yrs of age, whereas we had not encountered any 
Hepatoblastomas in children older than 4 years. .Weinberg et al reported a male 
predominance in Hepatoblastoma with a ratio of 1.4 : 1 to 2:1. In contrary, our 
study found a relative female preponderance of 1.3 : 1. 
 
In the series reported by Exelby et al, the most frequent clinical 
presentation was the presence of an abdominal mass accounting for 68% of 
cases.   
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We observed 90% cases with abdominal mass / distension. Pain 
abdomen (10%) and weight loss (10%) were uncommon features of presentation 
noted in our series. Though consistent with our findings, the series of Exelby 
reported a slight higher percentage of these features – pain abdomen 19%, 
weight loss 23%. 
 
Literature records that alpha foeto protein is markedly elevated in more 
than 90% of Hepatoblastomas and in many cases of Hepatocellular carcinoma. 
Our study noted marked increase in alpha foeto protein in 88% of cases of 
Hepatoblastoma. Levels were abnormal in 1 case of Hepatocellular carcinoma 
and 1 case of Hemangioendothelioma.  
 
Histopathological profile of our series revealed Hepatoblastoma as the 
commonest variety of tumour(65%). Other lesions were less common including 
10% Hemangioendothelioma, 10% secondaries liver and 5% each of Adenoma, 
Malignant mesenchymal hamartoma, Hepatoma. Finegold et al recorded 43% of 
cases in their series as Hepatoblastoma, followed by 23% Hepatoma, 6% 
mesenchymal hamartoma, 2% adenoma.  
 
Malignant tumors accounted for 85% (18 of 21 cases) in our series. This 
pattern of majority of malignancies among the liver tumors is observed in the 
literature with a quoted 66%. The single case of Hepatocellular carcinoma noted 
in our series was incidentally the oldest patient (8 yr old boy) in our series.  
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The youngest child in our study was a 3 week old neonate with 
Hemangioendothelioma.  
 
 Surgical resection is the most important therapeutic modality of liver 
tumors. Resection is curative for most of the benign tumors including adenoma 
and mesenchymal hamartoma.  
 
Treatment of Hemangioendothelioma is controversial, as a variety of 
alternative therapies to surgery are available namely arterial embolization, 
steroids, interferon and Cyclophosphamide, though with varying degrees of 
success. The PRETEXT staging system based on the number of liver sectors 
involved is helpful in determining the tumor resectability. Features that limit 
surgical resection of Hepatoblastoma include bilobar involvement, porta hepatis 
involvement and bulky lymphadenopathy. 
 
We use the triple drug regime consisting of Cisplatin, 5FU and Vincristine 
for chemotherapy of Hepatoblastoma, after submitting the patient to surgical 
resection. In accordance with the Pediatric Oncology group, we had adopted this 
regime, which is supposed to produce a 67% 4yr survival rate. Recent trials have 
reported the use of other regimes, including Cisplatin & Doxorubicin, Ifosfamide, 
Cisplatin & Doxorubicin with supposedly high overall survival rates of 75% at 5 
years. 
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 Prognostic factors determining survival post resection include 
complete tumour resection, degree of mitotic activity, pure foetal histology, 
reduction in the alpha foeto protein level, diploidy and proliferation index. 
Identification of the high risk individual for Hepatoblastoma, based on the 
presence of the known associations like Beckwith Wiedemann syndrome may 
facilitate early detection and enhance the ability to cure with limited therapy. 
 
It has been found out that in infants with Tyrosinemia type I, known to be 
at very high risk for Hepatoma, when treated with a chemical NTBC, the 
incidence of carcinoma was notably diminished,  
 
The most recent POG study achieved a survival of 90% in early stages of 
Hepatoblastoma with a significant fall in survival in advanced stages (67%). We 
in our series have achieved a 2 yr survival rate of 60%. All the 13 children are 
thriving well with good weight gain. Our recurrence rate of 14% was probably due 
to the non-anatomical resections undertaken in those children.  10% of our study 
cases were lost for follow up. Among the 3 recurrences, 2 were hepatoblastomas 
and one was adrenecortical ca with liver secondaries. 
 
Liver transplantation is fast catching up as an effective and attractive 
treatment modality for unresectable malignant tumors, in view of the improved 
survival post transplant. 
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So much so, that even large benign tumors deemed unfit for resection, 
have been successfully taken up for transplantation. 
 
Newer modalities which would be available in future, for treatment of 
Hepatoblastoma are Chemoembolization with thrombogenic agents containing 
Cisplatin or Doxorubicin, viral transfection vectors to specifically attack and 
destroy the malignant cells, and anti alpha foeto protein antibodies. 
 
 
Conclusion : 
 
I. Annual burden of new liver tumors registered in our Institute is 1-2% of 
the total number of malignancies  
II. Commonest liver tumor seen in our study is Hepatoblastoma, 
predominantly seen in age group less than 4 years 
III. Anatomical liver resections preferable to non anatomical resections 
IV. Outcome of liver resection is good with 60% 2 yr survival rate 
 
Further long term studies are required, to establish the role of neo 
adjuvant chemotherapy in liver tumors. Need to use vascular occlusion 
techniques, in the reduction of blood loss requires to be defined. 
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Table 1 Age, Gender and histopathological profile  
 
 
 
 
 
 
 
 
 
HPB  - Hepatoblastoma,   HE  - Hemangioendothelioma  Ad Ca  - Adrenocortical 
Ca with liver metastases,  Ma Me Ha  - Malignant Mesenchymal Hamartoma 
 
 
Table 2 Histopathology profile 
Age group Male Female Total 
< 1 yr 2 HPB 3 HPB, 1 HE 6 
1-2 yrs 3 HPB 4 HPB 7 
2-3 yrs 1 HPB, 1 HE 1 HPB 3 
4-5 yrs 1 Ad Ca 1 Adenoma 2 
6-7 yrs 1 Ma Me Ha 1 Ad Ca 2 
8-9 yrs 1 Hepatoma - 1 
 10 11 21 
Benign tumors   3 (15%) Malignant tumors  18 (85%) 
 
• Hepatic adenoma 1 
• Hemangioendotheioma 2 
 
• Hepatoblastoma 14 
• Malig Mesench Hamartoma 1 
• Hepatoma 1 
• Adrenocortical Ca with sec 
liver 2 
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Table 3  Clinical features 
Presentation Number of cases
Mass abdomen / 
distension 
 19  (90%) 
Anorexia     5  (23%0 
Fever    5  (23%) 
Failure to thrive    4  (20%) 
Weight loss    2  (10%) 
Pain abdomen    2  (10%) 
Pseudo precocious 
puberty 
   2  (10%) 
 
 
                            Table 4 Alpha foeto protein profile 
 
Levels ng/mL Cases 
> 30,000 6 HPB 
10,000 – 30,000 5 HPB 
1,000 – 10,000 3 HPB 
< 1,000 1 HE, 1Hepatoma 
normal 1 Adenoma, 1HE, 1 
MMH, 2 Ad Ca 
HPB  - Hepatoblastoma,   HE  - Hemangioendothelioma  Ad Ca  - Adrenocortical 
Ca with liver metastases,  MMH - Malignant Mesenchymal Hamartoma 
 
 
                        Table 5  Operative procedures 
 
Procedures cases 
Right hepatectomy 9 (44%) 
Left hepatectomy 7 (33%) 
Segmentectomy 1 (4%) 
Non anatomical 4 (19%) 
Re resection 3 (14%) 
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Table 6 Post op Complications 
             
 
 
 
 
                              Table 7 chemotherapy  
Neo adjuvant 2 HPB 
Post op 12 HPB, 1 Malig mesen hamartoma 
No Chemo 6 – 1 HA, 1 Hepatoma, 2 HE, 2 Ad ca 
HPB  - Hepatoblastoma,   HE  - Hemangioendothelioma  Ad Ca  -  Adrenal 
Ca with  liver metastases,  HA – Hepatic Adenoma 
 
 
 
 
Table 8  Outcome 
 
Status cases 
Doing well 13 (65%) 
Awaiting surgery  1 (4%) 
Death  5 (23%) 
Lost follow up  2 (8%) 
Bile leak 3 (2 settled, 1 reoperated) Immediate 
Bleed 5 (3 controlled, 2 died) 
Recurrences 4 (3 died, I reoperated) Late 
Incisional hernia 1 
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Figure 1 :   Age distribution of study cases 
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                Fig 3 Neonate with 
         Hypochondriac mass 
 
 
  
 
 
 
 
                                           Fig 4 Boy with Adrenocortical ca with Liver metastases 
 
 
 
 
 
 
 
 
            Mass abdomen           Premature Pubarche 
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                          Fig 5  Liver eviscerated with tumor 
 
     
 
 
 
 
 
 
 
 
 
 
    Fig 6 showing Right lobe liver mass 
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                       Fig 7 showing Left lobe liver mass 
    
  Fig 8 Vascular control taken prior to commencement of liver resection 
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                                                Fig 9 Post resection liver bed 
 
 
 
 
 
 
 
 
 
 
 
 
                   Fig 10  Digitoclasia in progress 
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     Fig 11 Resected Specimen  
        
     Segmentectomy specimen          Right hepatectomy specimen 
 
 
 
                 
 
              
                        
 
 
Specimen of Non anatomical resection                         Left hepatectomy 
            
         specimen 
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Fig 12 CT scan abdomen showing Left lobe liver tumor with necrosis          
 
 Fig 13 - Post resection, completed chemotherapy at 1 yr follow up 
 
 
 
